The extent of drug therapy for attention deficit-hyperactivity disorder among children in public schools

American Journal of Public Health

Volumn 89, Issue 9, 1999, Pages 1359-1364

  LeFever, Gretchen B ^a,b   Dawson, Keila V ^c   Morrow, Ardythe L ^a  

^a CHILDREN S HOSPITAL OF THE KING S DAUGHTERS   (United States)

^b CENTER FOR PEDIATRIC RESEARCH   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE; PSYCHOTROPIC AGENT;

ARTICLE; ATTENTION DEFICIT DISORDER; CAUCASIAN; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGRO; PREVALENCE; SEX DIFFERENCE;

EID: 0032807302     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.89.9.1359     Document Type: Article

References (40)

1. Shaywitz SE, Shaywitz BA. Attention deficit disorder: current perspectives. Pediatr Neurol. 1987;3:129-135.
2. Whalen C, Henker B, Buhrmester D, Hinshaw SP, Huber A, Laski K. Does stimulant medication improve the peer status of hyperactive children? J Consult Clin Psychol. 1989;57: 5435-5449.
3. Wolraich M, Hannah JN, Pinnock TY, Baumgaertel A, Brown J. Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sample. J Am Acad Child Adolesc Psychiatry. 1996;35:319-324.
4. LeFever G, Dawson K, Hannon P, Morrow A. Use of Ritalin among children in public schools. Paper presented at: Annual Meeting of Society for Pediatric Research; May 5, 1997; Washington, DC.
5. Wilens T, Biederman J. The stimulants. Psychiatr Clin North Am. 1992;15:191-222.
6. Methylphenidate Review. Washington, DC: US Dept of Justice, Drug Enforcement Administration; 1995.
7. Swanson JM, Lerner M, Williams L. More frequent diagnosis of attention deficit hyperactivity disorder [letter]. N Engl J Med. 1995;333: 944.
8. Wolraich M, Lindgren S, Stromquist R. Stimulant medication use by primary care physicians in the treatment of attention deficit hyperactivity disorder. Pediatrics. 1990;86:95-101.
9. Safer D, Zito JM, Fine EM. Increased methylphenidate usage for attention deficit disorder in the 1990s. Pediatrics. 1996;98:1084-1088.
10. Consensus Development Conference Statement: Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder. Bethesda, Md: National Institutes of Health; November 1998.
11. Bird HR, Canino G, Rubio-Stipec M, et al. Estimates of the prevalence of childhood maladjustment in a community survey in Puerto Rico. The use of combined measures [published correction appears in Arch Gen Psychiatry. 1994;51:429]. Arch Gen Psychiatry. 1988;45: 1120-1126.
12. Cohen P, Cohen J, Kasen S, et al. An epidemiological study of disorders in late childhood and adolescence, I: age- and gender-specific prevalence. J Child Psychol Psychiatry. 1993;34: 851-867.
13. Costello EJ, Costello AJ, Edelbrock C, et al. Psychiatric disorders in pediatric primary care: prevalence and risk factors. Arch Gen Psychiatry. 1988;45:1107-1116.
14. Esser G, Schmidt MH, Woerner W. Epidemiology and course of psychiatric disorders in school-aged children: results of a longitudinal study. J Child Psychol Psychiatry. 1990;31: 243-263.
15. Offord DR, Boyle MH, Szatmari P, et al. Ontario Child Health Study, II: six month prevalence of disorder and rates of service utilization. Arch Gen Psychiatry. 1987;44:832-836.
16. Reid R, Maag JW, Vasa SF, Wright G. Who are the children with attention deficit-hyperactivity disorder? A school-based survey. J Special Educ. 1994;28:117-137.
17. Szatmari P, Offord DR, Boyle MH. Ontario Child Health Study: prevalence of attention deficit disorder with hyperactivity. J Child Psychol Psychiatry. 1989;30:219-230.
18. Velez CN, Johnson J, Cohen P. A longitudinal analysis of selected risk factors for childhood psychopathology. J Am Acad Child Adolesc Psychiatry. 1989;28:861-864.
19. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). Washington, DC: American Psychiatric Association; 1994.
20. Barkley R. Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. New York, NY: The Guilford Press; 1990.
21. Richters J, Arnold LE, Jensen PS, et al. NIMH collaborative multisite multimodal treatment study of children with ADHD: background and rationale. J Am Child Adolesc Psychiatry. 1995; 34:987-1000.
22. Cantwell D, Baker L. Association between attention deficit-hyperactivity disorder and learning disabilities. J Learning Disabilities. 1991;24:88-95.
23. Zito JM, Safer DJ, dosReis S, Magder LS, Riddle MA. Methylphenidate patterns among Medicaid youths. Psychopharmacol Bull. 1997;33: 143-147.
24. Safer D, Allen RP. Stimulant drug treatment of hyperactive adolescents. Dis Nerv Syst. 1975; 36:454-457.
25. Safer DJ, Krager JM. A survey of medication treatment for hyperactive/inattentive students. JAMA. 1988;260:2256-2258.
26. Safer DJ, Krager JM. The increased rate of stimulant treatment for hyperactive/inattentive students in secondary schools. Pediatrics. 1994; 94:462-464.
27. Spanos E. Quotas, ARCOS, UN report and statistics. Paper presented at: Conference on Stimulant Use in the Treatment of ADHD; December 10-12, 1996; San Antonio, Tex.
28. Morrow R, Morrow AL, Haslip AL. Methylphenidate in the United States, 1990 through 1995 [research letter]. Am J Public Health. 1998;88:1121.
29. SPSS for Windows. Chicago, Ill: SPSS Inc; 1997.
30. Lang J. Ritalin nation: hyperactivity is the new world order. New Britain Herald. June 10, 1997:2.
31. Jensen P, Watanabe HK, Richters JE, Cortes R, Roper M, Liu S. Prevalence of mental disorders in military children and adolescents: findings from a two-stage community survey. J Am Acad Child Adolesc Psychiatry. 1995;34:1514-1524.
32. Findling R. Open label treatment for comorbid depression and attentional disorders with co-administration of serotonin reuptake inhibitors and psychostimulants in children, adolescents, and adults. J Child Adolesc Psychopharmacol. 1996;6:165-175.
33. Wilens T, Spencer T, Biederman J, Wozniak J, Connor D. Combined pharmacotherapy: an emerging trend in pediatric psychopharmacology. J Am Acad Child Adolesc Psychiatry. 1995;34:110-112.
34. Clay RA. Are children being overmedicated? Psychologists warn that children may be receiving inappropriate prescriptions. American Psychological Association Monitor. December 1997: 1, 27.
35. Gordon M. ADHD on trial. ADHD Rep. 1997; 5(4):1-4.
36. Vaughn B, LeFever GB, Seifer R, Barglow P. Attachment behavior, attachment security, and temperament during infancy. Child Devel. 1989;60:728-737.
37. Vaughn B, Stevenson-Hinde J, Waters E, et al. Attachment security and temperament in infancy and early childhood: some conceptual clarifications. Dev Psychol. 1992;28: 463-473.
38. Goldman L, Genel M, Bexman RJ, Slanetz PJ. Diagnosis and treatment of attention-deficit/ hyperactivity disorder in children and adolescents. JAMA. 1998;279:1100-1107.
39. Sroufe LA, Stewart MA. Treating problem children with stimulant drugs. N Engl J Med. 1975; 289:407-413.
40. Jacobvitz D, Sroufe LA, Stewart MA, Leffert N. Treatment of attentional and hyperactivity problems in children with sympathomimetic drugs: a comprehensive review. J Am Acad Child Adolesc Psychiatry. 1990;29: 677-688.